SCIENTIFIC AND INFORMATION-ANALYTICAL MAGAZINE

ISSN 1024-6177 (Print), ISSN 2618-9615 (Online)

Medical Radiology and Radiation Safety. 2018. Vol. 63. No. 3. P. 52-67

REVIEW

DOI: 10.12737/article_5b179d60437d54.24079640

Results of Randomized Studies on Hyperthermia in Oncology

O.K. Kurpeshev1, J. van der Zee2

1. A.F. Tsyb Medical Radiological Research Center, Obninsk, Russia, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. ; 2. Erasmus Medical Centre, Cancer Institute, Rotterdam, the Netherlands

O.K. Kurpeshev – Head of Dep., Dr. Sc. Med., Member of European Society for Hyperthermic Oncology (ESHO); J. van der Zee – Ph.D., MD, Member of European Society for Therapeutic Radiology and Oncology (ESTRO), European Society for Hyperthermic Oncology (ESHO)

Abstract

The review presents statistics of published randomized phase III trials on the addition of hyperthermia (HT) to other cancer therapies, and analyzes the results of these trials. In total, 47 comparisons could be made for treatments with or without HT. These trials were done in a large variety of solid tumors, and in centers in Asia, Europe, North America and Australia. In general, these studies were relatively small – 17 studies included more than 100 patients. The total number of patients was 5099. In the majority of the studies, HT was applied with electromagnetic radiation. Most studies (74 %) have shown that additional HT significantly improves the results of radiation, chemo- and chemoradiotherapy in patients with, in general, locally advanced relapsed and metastatic forms of malignant tumors. Improved results were reported for complete and overall response, loco-regional tumor control, disease free and overall survival, and, in one study, for palliative effects.

In these randomized trials also acute and/or late toxicity has been investigated. In the majority of the trials, addition of HT did not result in significant increases of toxic effects. The economic consequences of HT as part of cancer treatment are discussed.

Twenty-six percent of the studies failed to show a significant beneficial effect of HT which are discussed in more detail. In 4 studies with a trend of a better outcome in the plus HT treatment arm, with an absolute difference of 10 % or more, the lack of significance is probably due to a low number of patients included. In other studies, there was an unbalanced distribution of tumor characteristics over the two study arms, with worse prognostic factors in the plus HT arm, inadequate techniques, using too high frequency of electromagnetic radiation, and/or a small applicator, and/or a short heating time, so that a sufficient energy deposition in the tumor volume could not be achieved. These results make clear that it is important to develop guidelines for the application of HT, in addition to the existing ones. In view of the different principles of operation of HT applicators, it is important that such guidelines will become available for each individual device. Further, it is important to conduct larger randomized trials. Larger studies would probably increase the number of significant and also more relevant outcomes, and promote a wider acceptance of HT as part of cancer treatment.

Key words: hyperthermia, randomization, radiation therapy, chemotherapy, thermoradiotherapy, thermochemotherapy, thermochemoradiation therapy

REFERENCES

  1. Kurpeshev OK, Tsyb AF, Mardynsky YuS, et al. Local hyperthermia in radiation therapy of malignant tumors (experimental and clinical study). Obninsk; 2007. 219 p. Russian.
  2. Van der Zee J, Vujaskovic Z, Kondo M, Sugahara T. Part I. Clinical Hyperthermia. The Kadota Fund International Forum 2004. Clinical group consensus. Int J Hyperthermia. 2008;24(2):111-22.
  3. Kurpeshev OK, Mardinsky YuS, Maksimov SA. Combined treatment of patients with oral cancer using the “conditionally-dynamic” mode of fractionation of radiation therapy and loco-regional hyperthermia. Siberian Medical Review. 2011;67(1):80-4. Russian.
  4. Pankratov VA, Andreev VG, Kurpetshev OK et al. The use of thermochemical radiation treatment in patients with locally advanced laryngeal and laryngopharynx cancer. Russian Oncol. 2006;(4):20-3. Russian.
  5. Kurpeshev OK. Opportunities and prospects of using hyperthermia in medicine. Clinical medicine. 1996;(1):14-6. Russian.
  6. Datta NR, Ordonez SG, Gaipl US, et al. Local hyperthermia combined with radiotherapy and-/or chemotherapy: Recent advances and promises for the future. Cancer Treatment Reviews. 2015;41(9):742-53. DOI: 10.1016/j.ctrv.2015.05.009.
  7. Ohguri T. Current Status of Clinical Evidence for Electromagnetic Hyperthermia on Prospective Trials. Thermal Med. 2015;31(2):5-12.
  8. Wust P. Thermotherapy in Оncology. 1st edition. Bremen: UNI-MED; 2016. 95 p.
  9. Pang CLK. Hyperthermia in Oncology. Guangzhou University of Chinese medicine. CRC Press. Tylor & Francis Gr.; 2016. 353 p.
  10. Datta NR, Bose AK, Kapoor HK. Thermoradiotherapy in the management of carcinoma cervix (stage IIIB): A controlled clinical study. Indian Med. Gaz. 1987;121:68-71.
  11. Shchepotin IB, Evans SRT, Chorny V, et al. Intensive preoperative radiotherapy with local hyperthermia for the treatment of gastric carcinoma. Surg Oncol. 1994;3(1):37-44.
  12. Trotter JM, Edis AJ, Blackwell JB, et al. Adjuvant VHF therapy in locally recurrent and primary unresectable rectal cancer. Australas Radiol. 1996;40(3):298-305.
  13. Vasanthan A, Mitsumori M, Park JH, et al. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency. Int J Radiat Oncol Biol. Phys. 2005;61(1):145-53.
  14. Maslennikova AV. Thermal radiation and chemoradiotherapy of locally advanced cancer of the pharynx and larynx. N. Novgorod: Author. Diss. doctor. med. Sciences; 2008. 37 p. Russian.
  15. Flameling B, Nordberg T, Ott OJ, et al. An international multicentre phase III study of chemoradiotherapy versus chemoradiotherapy plus hyperthermia for locally advanced cervical cancer. Int J Gynecol Cancer; 2015:55-6 (conference abstract).
  16. Ghussen F, Nagel K, Groth W, et al. A prospective randomized study of regional extremity perfusion in patients with malignant melanoma. Ann Surg. 1984;200(6):764.
  17. Hafstrom L, Rudenstam CM, Blomquist E, et al. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group. J Clin Oncol. 1991;(9):2091-4.
  18. Chen J, Su Z, Song Z, Lin L. Clinical application of postoperative intraperitoneal hyperthermic perfusion combined with venoclysis for gastric cancer. China J of Cancer Prevention and Treatment. 2006;12:937-8.
  19. Ding WT, Duan DM, Sun GS, Gu C. Clinical observation on early intraperitoneal hyperthermic perfusion chemotherapy in the treatment of stomach carcinoma after operation. Tumor. 2007;27(7):585-7.
  20. Verwaal VJ. Long-term results of cytoreduction and HIPEC followed by systemic chemotherapy. Cancer J. 2009;15(3):212-5.
  21. Mi DH, Li Z, Yang KH, Cao N, et al. Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: A systematic review and meta-analysis of randomised controlled trials. Int J Hyperthermia. 2013;29(2):156-67.
  22. Sun J, Song Y, Wang Z, et al. Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials. BMC Cancer. 2012;12:526-36.
  23. Yang X-J, Huang C-Q, Suo T, et al. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial. Ann Surg. Oncol. 2011;18(6):1575-81.
  24. Olofsson R, Mattsson J, Hafström L. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities – Long-term follow-up of a randomised trial. Int J Hyperthermia. 2014;30(5):295-8. DOI: 10.3109/02656736.2014.931601.
  25. Sherar M, Liu FF, Pintilie M, et al. Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial. Int J Radiat Oncol Biol Phys. 1997;39(2):371-80.
  26. Jones EL, Oleson JR, Prosnitz LR, et al. Randomized trial of hyperthermia and radiation for superficial tumors. J Clin Oncol. 2005;23:3079-85.
  27. Engin K, Tupchong L, Moylan DJ, et al. Randomized trial of one versus two adjuvant hyperthermia treatments per week in patients with superficial tumours. Int J Hyperthermia. 1993;9(3):327-40. DOI: 10.3109/02656739309005034.
  28. Lutgens LS, Koper PC, Jobsen JJ, et al. Radiation therapy combined with hyperthermia versus cisplatin for locally advanced cervical cancer: Results of the randomized RADCHOC trial. Radiother. Oncol. 2016;120(3):378-82. DOI: 10.1016/j.radonc.2016.02.010.
  29. Ba M, Long H, Wang Y, et al. Intrapleural hyperthermic perfusion using distilled water at 48 °C for malignant pleural effusion. J Cancer Res. and Clin. Oncol. 2013;139(12):2005-12.
  30. Sulyok I, Fleischmann E, Stift A, et al. Effect of preoperative fever-range whole-body hyperthermia on immunological markers in patients undergoing colorectal cancer surgery. Brit J Anaesthesia. 2012;109(5):754-61. DOI: 10.1093/bja/aes248.
  31. Rijnen Z, Togni P, Roskam R, et al. Quality and comfort in head and neck hyperthermia: A redesign according to clinical experience and simulation studies. Int J Hyperthermia. 2015;31(8):823-30. DOI: 10.3109/02656736.2015.1076893.
  32. Yan XY, Liu WC, Yan ZS, Ma J. Efficacy and safety radio-chemotherapy combined with thermotherapy for cervical cancer: a meta-analysis. Chin J Evid-Based Med. 2014;14:752-8.
  33. Vernon CC, Hand JW, Field SB, et al. (International Collaborative Hyperthermia Group). Hyperthermia in the treatment of superficial localized primary and recurrent breast cancer – results from five randomized controlled trials. Int J Radiat Oncol Biol Phys. 1996;35:731-44.
  34. Van der Zee J, Gonzales, Gonzales D, van Rhoon GO, et al. Comparison of radiotherapy plus hyperthermia in locally advanced pelvic tumors: a prospective, randomised, multicentre trial. Lancet. 2000;355:1119-25.
  35. Issels RD, Lindner LH, Verweij J, et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. The Lancet Oncol. 2010;11(6):561-70. DOI:10.1016/S1470-2045(10)70071-1.
  36. Angele MK, Albertsmeier M, Prix NJ, et al. Effectiveness of Regional Hyperthermia With Chemotherapy for High-Risk Retroperitoneal and Abdominal Soft-Tissue Sarcoma After Complete Surgical Resection: A Subgroup Analysis of a Randomized Phase-III Multicenter Study. Ann Surg. 2014;260(5):749-56.
  37. Chen HW, Fan JJ, Luo W. A randomized trial of hyperthermo-radiochemotherapy for uterine cervix cancer. Chinese J Clin Oncol. 1997;24:249-51.
  38. Marmor JB, Hahn GM. Combined radiation and hyperthermia in superficial human tumors. Cancer. 1980;46(9):1986-91.
  39. Overgaard J, Gonzalez Gonzalez D, Hulshof MC, et al. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet. 1995;345:540-3.
  40. Emami B, Scott C, Perez CA, et al. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group. Int J Radiat Oncol Biol Phys. 1996;34(5):1097-104.
  41. Egawa S, Tsukiyama I, Watanabe S, et al. A randomized clinical trial of hyperthermia and radiation versus radiation alone for superficially located cancers. J Jpn. Soc. Ther. Radiol. Oncol. 1989;1:135-40.
  42. Perez CA, Pajak T, Emami B, et al. Randomized phase III study comparing irradiation and hyperthermia with irradiation alone in superficial measurable tumors. Final report by the Radiation Therapy Oncology Group. Am. J Clin Oncol. (CCT) 1991;14(2):133-41.
  43. Sneed PK, Stauffer PR, McDermott W, et al. Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 1998;40:287-95.
  44. Valdagni R, Amichetti M, Pani G. Radical radiation alone versus radical radiation plus microwave hyperthermia for N3 (TNM-UICC) neck nodes: A prospective randomized clinical trial. Int J Radiat Oncol Biol Phys. 1988;15:13-24.
  45. Valdagni R, Amichetti M. Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymphnodes in stage IV head and neck patients. Int J Radiat Oncol Biol Phys. 1993;28:163-9.
  46. Datta NR, Bose AK, Kapoor HK, Gupta S. Head and neck cancers: Results of thermoradiotherapy versus radiotherapy. Int J Hyperthermia. 1990;6:479-86.
  47. Huilgol NG, Gupta S, Sridhar CR. Hyperthermia with radiation in the treatment of locally advanced head and neck cancer: a report of randomized trial. J Cancer Res Ther. 2010;6:492-6.
  48. Hua Y, Ma S, Fu Z, et al. Intracavity hyperthermia in nasopharyngeal cancer: A phase III clinical study. Int J Hyperthermia. 2011;27(2):180-6. DOI:10.3109/02656736.2010.503982.
  49. Wang J, Li D. A clinical study on intraluminal hyperthermia combined with external irradiation for esophageal carcinoma. Chinese J Cancer Res. 1996;8(3):200-4.
  50. Mitsumori M, Zhi-Fan Z, Oliynychenko P, et al. Regional hyperthermia combined with radiotherapy for locally advanced non-small cell lung cancers: a multiinstitutional prospective randomized trial of the International Atomic Energy Agency. Int J of Clin. Oncol. 2007;12(3):192-8.
  51. Sharma S, Patel FD, Sandhu AP, et al. A prospective randomized study of local hyperthermia as a supplement and radiosensitizer in the treatment of carcinoma of the cervix with radiotherapy. Endocuriether/Hyperthermia Oncol. 1989;5:151-9.
  52. Franckena M, Stalpers LJA, Koper PCM, et al. Longterm improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the dutch deep hyperthermia trial. Int J Radiat Oncol Biol Phys. 2008;70(4):1176-82.
  53. Harima Y, Nagata K, Harima K, et al. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. Int J Hyperthermia. 2001;17(2):97-105.
  54. Kakehi M, Ueda K, Mukojima T, et al. Multi-institutional clinical studies on hyperthermia combined with radiotherapy or chemotherapy in advanced cancer of deep-seated organs. Int J Hyperthermia. 1990;6(4):719-40.
  55. You Q-S, Wang R-Z, Suen G-Q, et al. Combination preoperative radiation and endocavitary hyperthermia for rectal cancer: Long-term results of 44 patients. Int J Hyperthermia. 1993;9(1):19-24.
  56. Van der Zee J, Gonzales, Gonzales D. Regional hyperthermia for rectal cancer - Autors’ reply. Lancet. 2000;356:772.
  57. Strotsky AV, Fradkin SZ, Zhavrid EA, Karpovick UA. Combined therapy of bladder cancer with the use of hyperthermia. Strahlenther Onkol. 1991;161:346.
  58. Colombo R, Da Pozzo LF, Lev A, et al. Neoadjuvant combined microwave induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superficial bladder cancer. J Urol. 1996;155(4):1227-32.
  59. Colombo R, Da Pozzo LF, Salonia A, et al. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin Oncol. 2003;21(23):4270-76.
  60. Colombo R, Salonia A, Leib Z, et al. Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC). BJU International. 2011;107(6):912-8.
  61. Fujimura T, Yonemura Y, Muraoka K, et al. Continuous Hyperthermic Peritoneal Perfusion for the Prevention of Peritoneal Recurrence of Gastric Cancer: Randomized Controlled Study. World J Surg. 1994;18:150-5.
  62. Yonemura Y, de Aretxabala X, Fujimura T, et al. Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study. Hepatogastroenterology. 2001;48:1776-82.
  63. Vargas HI, Dooley WC, Fenn AJ, et al. Study of preoperative focused microwave phased array thermotherapy in combination with neoadjuvant anthracycline-based chemotherapy for large breast carcinomas. Cancer Therapy. 2007;5:401-8.
  64. Sugimachi K, Kuwano H, Ide H, et al. Chemotherapy combined with or without hyperthermia for patients with oesophageal carcinoma: a prospective randomized trial. Int J Hyperthermia. 1994;10(4):485-93.
  65. Kondo M, Itani K, Yoshikawa T, et al. A prospective randomized clinical trial comparing intra-arterial chemotherapy alone and when combined with hyperthermia for metastatic liver cancer. Gan To Kagaku Ryoho 1995;22:1807-11.
  66. Song H, Chen L, Wang J, et al. Regional hyperthermia combined with intrapleural chemotherapy in patients with malignant pleural effusion. Chinese-German J Clinical Oncol. 2011;10(6):360-5.
  67. Engelhardt R, Neumann H, Muller U, Lohr GW. Clinical studies in whole body hyperthermia. In: Sugahara T. and Saito M. editors. Hyperthermic Oncology; 2. London: Taylor and Francis; 1989 p. 509-10.
  68. Zolciak-Siwinska A, Piotrkowicz N, Jonska-Gmyrek J, et al. HDR brachytherapy combined with interstitial hyperthermia in locally advanced cervical cancer patients initially treated with concomitant radiochemotherapy – a phase III study. Radiother. Oncol. 2013;100:194-9.
  69. Yan XY, Liu WC, Yan ZS, Ma J. Efficacy and safety radio-chemotherapy combined with thermotherapy for cervical cancer: a meta-analysis. Chin J Evid-Based Med. 2014;14:752-8.
  70. Harima Y, Ohguri T, Imada H, et al. A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer. Int J Hyperthermia. 2016;32(7):801-8.
  71. Kang M, Liu W.Q, Qin YT, et al. Long-term efficacy of microwave hyperthermia combined with chemoradiotherapy in treatment of nasopharyngeal carcinoma with cervical lymph node metastasis. Asian Pac J Cancer Prev. 2013;14:7395-400.
  72. Zhao C, Chen J, Yu B, Chen X. A new therapeutic option for nasopharyngeal carcinoma. Improvement in quality of life in patients with nasopharyngeal carcinoma treated with non-invasive extracorporeal radiofrequency in combination with chemoradiotherapy. Int J Radiat Biol. 2014;90(10):853-8. DOI: 10.3109/09553002.2014.916579.
  73. Kitamura K, Kuwano H, Watanabe M, et al. Prospective randomized study of hyperthermia combined with chemoradiotherapy for esophageal carcinoma. J Surg Oncol. 1995;60(1):55-8.
  74. Sun J, Guo M, Pang H, et al. Treatment of malignant glioma using hyperthermia. Neural Regen Res. 2013;8(29):2775-82. DOI: 10.3969/j.issn.1673-5374.2013.29.009.
  75. Casali PG, Jost L, Sleijfer S et al. Soft tissue sarcomas: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. On behalf of the ESMO Guidelines Working Group. Ann Oncol. 2008;19(Suppl 2):1189-93. DOI:10.1093/annonc/mdn101.
  76. Varma S, Myerson R, Moros E, et al. Simultaneous radiotherapy and superficial hyperthermia for high-risk breast carcinoma: A randomised comparison of treatment sequelae in heated versus non-heated sectors of the chest wall hyperthermia. Int J Hyperthermia. 2012;28(7):583-90. DOI:10.3109/02656736.2012.705216.
  77. Sharma S, Sandhu AP, Patel FD, et al. Side-effects of local hyperthermia results of a prospectively randomized clinical study. Int J Hyperthermia. 1990;6(2):279-85.
  78. Rietbroek RC, Bakker PJ, Schilthuis MS, et al. Feasibility, toxicity, and preliminary results of weekly loco-regional hyperthermia and cisplatin in patients with previously irradiated recurrent cervical carcinoma or locally advanced bladder cancer. Int J Radiat Oncol Biol Phys. 1996;34(4):887-93.
  79. Maluta SJ, Omano M, Dall’oglio S, et al. Regional hyperthermia added to intensified preoperative chemo-radiation in locally advanced adenocarcinoma of middle and lower rectum. Int J Hyperthermia. 2010;26(2):108-17.
  80. Inman BA, Stauffer PR, Craciunescu O, et al. A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for non-muscle-invasive bladder cancer. Int J Hyperthermia. 2014;30(3):171-5. DOI:10.3109/02656736.2014.882021.
  81. Van der Zee J, Van Rhoon GC, Wust P. In regard to Dr Vasanthan et al. Int J Radiat Oncol Biol Phys 2005;61:145-53.
  82. Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int.J Radiat Oncol Biol Phys. 1984;10:787-800.
  83. Dewhirst MW, Gibbs FAQ, Roemer RB, Samulski TV. Hyperthermia. In: Clinical Radiation Oncology. Ed. by Gunderson L.L, Tepper J.E.). A Harcourt Health Sciences Company. New York, Edinburg, Philadelphia; 2006. Ch. 14. p. 256-82.
  84. Astrahan M, Liggett P, Petrovich Z, Luxton G. A 500 KHz localized current field hyperthermia system for use with ophthalmic plaque radiotherapy. Int J hyperthermia. 1987;3:423-32.
  85. Lee D-J, O’Nell M, J, Lam K-S, et al. A new design of microwave interstitial applicators for hyperthermia with improved treatment volume. Int J Radiation Oncology Biol. Phys. 1986;12(11):2003-8.
  86. De Wit GA, de Charro FT, van der Zee J, van Rhoon GC. Economic evaluation of a new cancer treatment: hyperthermia in the management of advanced pelvic cancer. 10th Annual Meeting of the International Society of Technology Assessment in Health Care (ISTAHC). Baltimore, USA. 1994. Abstract No. 203.
  87. Van der Zee J, González González D. The Dutch Deep Hyperthermia Trial: results in cervical cancer. Int J Hyperthermia. 2002;18(1):1-12.
  88. Kok HP, Correia D, der Greef M, et al. SAR deposition by cured CFMA-434 applicators for superficial hyperthermia: Measurements and simulations. Int J Hyperthermia. 2010;26(2):171-84.
  89. Kozlov AA. The role of microwave hyperthermia in the palliative treatment of prostate cancer patients and relapses of bladder cancer. Author’s abstract of PhD Med. St. Petersburg; 2006. 24 p. Russian.
  90. Kouloulias V, Triantopoulou S, Vrouvas J, et al. Combined chemoradiotherapy with local microwave hyperthermia for treatment of T3N0 laryngeal carcinoma: a retrospective study with long-term follow-up. Acta Otorhinolaryngol Ital. 2014;34(3):167-73.
  91. Malikhov GG. Combined and complex treatment of patients with squamous cell carcinoma of the anal canal. Author’s abstract. diss. PhD Med. Moscow; 2004. 23 p. Russian.
  92. Kim DF. Combined organ-preserving treatment of patients with squamous cell carcinoma of the anal canal. Author’s abstract. diss. PhD Med. Moscow; 2014. 24 p. Russian.
  93. Ito K, Furuya K. Basics of microwave interstitial hyperthermia. Jpn. J Hyperthermic Oncol. 1996;12(1):8-21.
  94. Novruzov II, Komarov VV. Investigation of electromagnetic and thermal fields in the near zone of a contact waveguide applicator. Technical sciences. Electronics, measuring and radio-engineering. 2011;20(4):151. Russian.
  95. Kreynina YuM, Shevchenko LN, Kaskulova MKh. Chemothermoradiotherapy in patients with cervical cancer with various types of parametric infiltration. Proceedings of I All-Russian Congress RATRO. “New technologies in radiotherapy and nuclear medicine. Development prospects”. April 27-28, 2017. Sochi; 2017. p. 65. Russian.
  96. Sahinbas H. Retrospective clinical study for advanced brain gliomas by adjuvant electro-hyperthermia Treatment. Cancer Therapy. 2012;8:139-49.
  97. Rusakov SV, Sas A, Sas O, Sas N. Method of treatment of solid malignant tumors by oncothermia (medical technology). Moscow; 2011. 96 p. Russian.
  98. Borbenyi E, Szasz AM, Muhl D, Kiss E, Kvasnika M, Toth A, Torgyik L, Dank H.M. Modulated Electro-Hyperthermia in Oligometastatic Cancer Patients: initial experience and clinicopathologic evaluation. 31rd Annual Meeting of the European Society for Hyperthermic Oncology. 21-23 June, 2017. Athens, Greece; 2017. p. 40-1.
  99. Startseva ZhA, Choinzonov EL, Gribova OV, Simonov KA. Local hyperthermia is an effective method of radiomodification in combined treatment of patients with malignant neoplasms. Proceedings of the I All-Russian Congress RATRO. “New technologies in radiotherapy and nuclear medicine. Development prospects”. Sochi; 2017. p. 102. Russian.
  100. Noh JM, Kim HY, Park HC, et al. In vivo verification of regional hyperthermia in the liver. Radiat Oncol J. 2014;32(4):256-61.
  101. Yu JI, Park HC, Choi DH. Prospective phase II trial of regional hyperthermia and whole liver irradiation for numerous chemorefractory liver metastases from colorectal cancer. Radiat Oncol J. 2016;34(1):34-44. DOI: 10.3857/roj.2016.34.1.34.

For citation: Kurpeshev OK, van der Zee J. Results of Randomized Studies on Hyperthermia in Oncology. Medical Radiology and Radiation Safety. 2018;63(3): 52-67. Russian. DOI: 10.12737/article_5b179d60437d54.24079640

PDF (RUS) Full-text article (in Russian)

© Журнал "Медицинская радиология и радиационная безопасность" 2020г.

Яндекс.Метрика

Наверх